Viemed Healthcare, Inc. Ratios | P/E, ROE & Valuation

On the Key Ratios page for Viemed Healthcare, Inc. (VMD), the latest P/E of 23.8 frames valuation, while ROE 10.30% and ROIC 11.00% indicates profitability and capital efficiency. Together with the current ratio of 1.13 and debt-to-equity 0.08, these signals help you judge whether valuation is supported by fundamentals across the historical rows.

Financial Performance Ratios

VMD Historical Per Share Metrics

10 years
Metric (FY)TTM202420232022202120202019201820172016
Revenue per Share$7.89$5.79$4.77$3.59$2.96$3.39$2.13$1.72$1.24$0.83
Net Income per Share$0.38$0.29$0.27$0.16$0.23$0.81$0.23$0.27$0.22$0.03
Operating Cash Flow per Share$1.59$1.01$1.18$0.72$0.57$0.91$0.51$0.59$0.32$0.17
Free Cash Flow per Share$0.76$0.03$0.50$0.13$0.07$0.57$0.15$0.43$0.21$0.13
Cash per Share$0.28$0.45$0.33$0.39$0.72$0.80$0.35$0.27$0.13$0.11
Book Value per Share$3.82$3.44$2.97$2.51$2.40$2.11$1.16$0.92$0.63$0.34
Tangible Book Value per Share$2.25$2.57$2.18$2.51$2.40$2.11$1.16$0.92$0.63$0.34
Interest Debt per Share$0.34$0.20$0.28$0.02$0.17$0.30$0.53$0.10$0.14$0.18
CAPEX per Share$0.82$0.97$0.68$0.59$0.50$0.34$0.35$0.16$0.11$0.04

VMD Historical Valuation Ratios

10 years
Metric (FY)TTM202420232022202120202019201820172016
Price to Earnings (P/E)23.8127.5929.3946.9722.599.5427.4314.158.3255.37
Price to Book (P/B)2.382.372.643.012.173.685.354.112.865.28
Price to Sales (P/S)1.131.391.652.11.762.292.912.211.452.17
Enterprise Value to EBITDA6.47.098.1311.498.449.215.379.865.9938.82
EV to Sales1.141.341.631.991.572.142.992.11.452.24
EV to Operating Cash Flow5.647.686.69.958.19812.576.125.6610.94
EV to Free Cash Flow11.73227.7215.6256.9166.9812.7342.098.438.4914.8
Enterprise Value$342.95M$300.14M$298.56M$276.01M$184.25M$280.80M$240.00M$137.00M$68.08M$70.15M

VMD Historical Profitability Ratios

10 years
Metric (FY)TTM202420232022202120202019201820172016
Return on Equity (ROE)10.30%8.57%8.99%6.41%9.62%38.60%19.51%29.05%34.43%9.53%
Return on Invested Capital (ROIC)11.00%8.96%8.17%5.76%8.24%33.07%11.67%42.40%30.45%22.28%
Return on Tangible Assets10.06%7.86%8.22%5.32%7.74%28.01%10.32%19.01%21.69%4.98%
Earnings Yield4.22%3.62%3.40%2.13%4.43%10.49%3.65%7.07%12.02%1.81%
Free Cash Flow Yield8.55%0.42%6.35%1.66%1.33%7.34%2.44%11.29%11.80%6.97%
Dividend Yield0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

VMD Historical Liquidity & Financial Strength

10 years
Metric (FY)TTM202420232022202120202019201820172016
Current Ratio1.131.421.192.112.662.051.071.351.291.22
Interest Coverage17.2523.0733.841.8936.4252.6127.8694.1732.441.19
Income Quality4.083.434.414.462.461.112.242.21.475.22
Debt to Equity0.080.050.090.010.070.140.450.10.220.5
Debt to Assets5.68%3.88%6.67%0.59%5.53%9.89%23.62%6.40%13.74%26.30%
Net Debt to EBITDA0.02-0.25-0.07-0.68-1-0.650.39-0.50.011.19

VMD Historical Efficiency Ratios

10 years
Metric (FY)TTM202420232022202120202019201820172016
Receivables Turnover9.3699.929.017.9510.616.967.384.86.54
Payables Turnover11.759.759.4820.4313.4824.435.162.843.646.64
Inventory Turnover24.521.0815.1715.1517.7722.1617.835.787.547.63
Days Sales Outstanding3940.5536.840.545.8834.3952.4649.4376.0855.79
Days Payables Outstanding31.0737.4338.5117.8627.0814.9470.74128.69100.3755
Days of Inventory on Hand14.917.3224.0524.0920.5416.4720.4763.1448.4147.84

VMD Historical Market Metrics

10 years
Metric (FY)TTM202420232022202120202019201820172016
Enterprise Value to EBITDA6.47.098.1311.498.449.215.379.865.9938.82
Market Cap$342.03M$310.82M$301.08M$292.23M$206.14M$300.65M$233.84M$143.99M$67.99M$67.99M
Enterprise Value$342.95M$300.14M$298.56M$276.01M$184.25M$280.80M$240.00M$137.00M$68.08M$70.15M
Dividend Yield0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Payout Ratio0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions

How does Viemed Healthcare, Inc.’s P/E ratio compare with its history?

On this page, VMD's current P/E is 23.8, compared with a multi-year average around 26.5. A lower P/E versus its own history is a calculated gap versus that average—not a conclusion that the stock is cheap. Pair it with profitability and earnings quality in the table (for example ROE/ROIC) to see whether the multiple moved with earnings.

What is Viemed Healthcare, Inc. market cap?

Market cap is the market value of a company's equity and is commonly calculated as share price multiplied by shares outstanding. The latest market cap shown in the table is $342.03M. Pair market cap with valuation multiples (P/E, P/B, P/S) so you can evaluate whether size also corresponds with "quality" and profitability. For a wider view across stocks, you can also use the stock screener.

How does Viemed Healthcare, Inc.’s P/E compare with its industry?

There is no P/E Tickerplace rates as good. Compare the P/E on this page with Viemed Healthcare, Inc.'s own historical range (in the table) and with peers via the Screener and Compare tools. A higher or lower multiple versus peers is a calculated gap, not a recommendation.

How does Viemed Healthcare, Inc. compare to its competitors in key financial ratios?

The fastest way to compare Viemed Healthcare, Inc. with competitors is to use the built-in "Peers Comparison" section on this page and the Compare tool. Focus on a small set of ratios that work together: P/E for valuation, ROE/ROIC for profitability and capital efficiency, current ratio and interest coverage for liquidity and solvency, and debt-to-equity for leverage risk. When you see Viemed Healthcare, Inc. outperform peers on profitability while keeping valuation and leverage reasonable, it often signals stronger fundamentals.

What do Viemed Healthcare, Inc.'s liquidity and leverage ratios show?

Liquidity and leverage figures on this page are published ratios, not a verdict that Viemed Healthcare, Inc. is financially strong. Current ratio is about 1.13, which is above 1.0 and can indicate more comfortable short-term liquidity. Interest coverage is about 17.25, implying a stronger ability to cover interest expenses. Debt-to-equity is about 0.08, suggesting leverage is more moderate relative to a high-debt profile. Pair them with ROE/ROIC and cash-flow rows in the table. Tickerplace does not rate the company as a good or poor investment.

What do Viemed Healthcare, Inc.'s financial ratios say about its future growth?

Ratios are a way to see what the business is likely to sustain. Look for upward trends in profitability metrics (ROE and ROIC), improving earnings/cash-flow backed measures, and stable or strengthening liquidity. If Viemed Healthcare, Inc. is sustaining strong returns (for example ROE at 10.30% and ROIC at 11.00%) while debt levels and interest coverage remain manageable, growth expectations may be more credible. If valuation multiples expand while returns weaken, the market may be pricing optimistic growth ahead of results.